Ranitidine Tablet

Product Price :Get Latest Price

Product Details:

Each Ml. Contains: Ranitidine Hydrochloride IP 25mg. Eq. To Ranitidine Phenol 0.5% W/v (As Preservative) Water For Injection IP Q.s.
RANIPLAY Injection (Ranitidine 25 mg / mL)

Healthy Inc offers RANIPLAY, an essential H₂-receptor antagonist (Histamine-2 blocker) for rapid gastrointestinal relief. Containing 25 mg of Ranitidine per mL, this formulation is a clinical priority for the treatment of duodenal ulcers, gastric ulcers, and GERD, and specifically for the prevention of acid aspiration syndrome during anesthesia. As a specialized Indian export partner, we supply this fundamental GI therapeutic to surgical units and primary care centers in global pharmaceutical markets.

• Clinical Precision: Effectively inhibits both daytime and nocturnal basal gastric acid secretion. Its rapid onset when administered via Intravenous (IV) or Intramuscular (IM) injection makes it indispensable for patients who cannot tolerate oral medication.

• Manufacturing Excellence: Produced in associated WHO-GMP certified sterile facilities. The solution is formulated under strict aseptic conditions to ensure 100% sterility, high molecular purity, and precise pH balance for safe administration.

• Climate Stability: Validated for Zone IVb (Hot/Humid) conditions; the formulation is stabilized to prevent degradation and maintain chemical integrity across the tropical climates of Africa, LATAM, and SEA markets.

• Regulatory Support: Full technical documentation available, including CTD/eCTD Dossiers, to streamline the registration of essential gastro-care therapeutics.

Accepting B2B inquiries for contract manufacturing, bulk supply, and hospital distribution partnerships from our Mumbai export hub.

Available strengths and packaging? We supply RANIPLAY in the standard 50 mg / 2 mL concentration, presented in 2 mL clear or amber USP Type I glass ampoules. Every batch undergoes rigorous HPLC-based assay testing and sterility validation to meet international standards.

Support for tropical export? Yes. RANIPLAY is Zone IVb stability-tested. We utilize neutral glass ampoules and moisture-resistant secondary packaging to ensure product stability during international transit to high-temperature regions.

Registration assistance provided? We provide complete Regulatory Technical Files (CTD) and Certificates of Analysis (COA) to facilitate local health authority approvals and government healthcare or surgical tender participations in your specific territory.

Small-volume or mixed orders? We specialize in mixed-container consolidation, allowing you to combine RANIPLAY with other essential injectables (such as Metoclopramide, Pantoprazole, or Ondansetron) in a single, cost-effective shipment.

Direct sourcing? Products are sourced through Healthy Life Group’s associated WHO-GMP manufacturing units, ensuring competitive direct-from-factory pricing and strict quality control oversight for essential gastro-care.